The lncRNA PVT1/miR-423-5p axis is positively correlated with the severity of bronchial asthma
Main Article Content
Keywords
bronchial asthma, LncRNA PVT1, miR-423-5p, receiver operating characteristic curve, serum
Abstract
Bronchial asthma (BA) is a serious problem affecting the quality of life of patients. Long noncoding RNAs (lncRNAs) are involved in BA. This study set out to investigate expressions of PVT1/miR-423-5p in the serum of BA patients and its clinical value on BA diagnosis and evaluation. This study included the same number (N = 100) of patients with BA at remission (BA-R), BA at exacerbation (BA-E), and healthy controls. PVT1 level was increased in BA-R and BA-E patients, and PVT1 level was higher in BA-E patients than BA-R patients. miR-141-3p targeted PVT1. miR-423-5p was downregulated in the serum of BA patients and was negatively correlated with PVT1. Area under ROC curve of PVT1/miR-423-5p axis on BA-R patients was 0.837 with sensitivity 0.74, specificity 0.84, while that of BA-E was 0.974 with sensitivity 0.87 and specificity 0.95. PVT1/miR-423-5p axis was negatively correlated with FEV1/FVC, FEV1% pred, and IL-10, and positively correlated with IgE, TNF-α, and IL-6. PVT1 and PVT1/miR-423-5p axis were associated with increased severity while miR-423-5p axis was negatively associated with BA severity. In conclusion, increased levels of PVT1/miR-423-5p had higher diagnostic efficiency on BA patients, especially patients with acute exacerbation.
References
2. Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019 Apr 16;50(4):975–991. 10.1016/j.immuni.2019.03.018
3. Michalik M, Wojcik-Pszczola K, Paw, Wnuk M, Koczurkiewicz D, Sanak P, et al. Fibroblast-to-myofibroblast transition in bronchial asthma. Cell Mol Life Sci. 2018 Nov;75(21):3943–3961. 10.1007/s00018-018-2899-4
4. Upham JW, James LM. Remission of asthma: the next therapeutic frontier? Pharmacol Ther. 2011 Apr;130(1):38–45. 10.1016/j.pharmthera.2011.01.002
5. Maselli DJ, Peters JI. Medication regimens for managing acute asthma. Respir Care. 2018 Jun;63(6):783–796. 10.4187/respcare.05953
6. Al-Busaidi N, Habibulla Z, Bhatnagar M, Al-Lawati N, Al-Mahrouqi Y. The burden of asthma in Oman. Sultan Qaboos Univ Med J. 2015 May;15(2):e184–e190.
7. Croisant S. Epidemiology of asthma: prevalence and burden of disease. Adv Exp Med Biol. 2014;795:17–29. 10.1007/978-1-4614-8603-9_2
8. Narozna B, Langwinski W, Szczepankiewicz A. Non-coding RNAs in pediatric airway diseases. Genes (Basel). 2017 Nov 27;8(12). 10.3390/genes8120348
9. Booton R, Lindsay MA. Emerging role of microRNAs and long noncoding RNAs in respiratory disease. Chest. 2014 Jul;146(1):193–204. 10.1378/chest.13-2736
10. Zhang J, Zhu Y, Wang R. Long noncoding RNAs in respiratory diseases. Histol Histopathol. 2018 Aug;33(8):747–756.
11. Ma L, Zhang Q, Hao J, Wang J, Wang C. LncRNA PVT1 exacerbates the inflammation and cell-barrier injury during asthma by regulating miR-149. J Biochem Mol Toxicol. 2020 Nov;34(11):e22563. 10.1002/jbt.22563
12. Austin PJ, Tsitsiou C, Boardman E, Jones SW, Lindsay MA, Adcock IM, et al. Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. J Allergy Clin Immunol. 2017 Mar;139(3):780–789. 10.1016/j.jaci.2016.06.014
13. Li S, Ye X, Lu Y. Long non-coding RNA NEAT1 overexpression associates with increased exacerbation risk, severity, and inflammation, as well as decreased lung function through the interaction with microRNA-124 in asthma. J Clin Lab Anal. 2020 Jan;34(1):e23023. 10.1002/jcla.23023
14. Qiu YU, Y Wu, MJ Lin, T Bian, YL Xiao, C Qin. LncRNA-MEG3 functions as a competing endogenous RNA to regulate Treg/Th17 balance in patients with asthma by targeting microRNA-17/RORgammat. Biomed Pharmacother. 2019 Mar;111:386–394. 10.1016/j.biopha.2018.12.080
15. Ye S, Zhu S, Feng L. LncRNA ANRIL/miR-125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma. J Clin Lab Anal. 2020 Mar;34(3):e23092. 10.1002/jcla.23092
16. Herbert C, Sebesfi M, Zeng QX, Oliver BG, Foster PS, Kumar rK. Using multiple online databases to help identify microRNAs regulating the airway epithelial cell response to a virus-like stimulus. Respirology. 2015 Nov;20(8):1206–1212. 10.1111/resp.12606
17. Schmittgen TD , Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. 10.1038/nprot.2008.73
18. Zhang XY, Tang XY, Li N, Zhao LM, Guo Y, Li XS, et al. GAS5 promotes airway smooth muscle cell proliferation in asthma via controlling miR-10a/BDNF signaling pathway. Life Sci. 2018 Nov 1;212:93–101. 10.1016/j.lfs.2018.09.002
19. Toskala E, Kennedy DW. Asthma risk factors. Int Forum Allergy Rhinol. 2015 Sep;5(Suppl 1):S11–S16. 10.1002/alr.21557
20. Li Y, Yin Z, Fan J, Zhang S, Yang W. The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal Transduct Target Ther. 2019;4:47. 10.1038/s41392-019-0080-7
21. Del Giacco S, Bakirtas R, Bel A, Custovic E, Diamant A, Hamelmann E, et al. Allergy in severe asthma. Allergy. 2017 Feb;72(2):207–220. 10.1111/all.13072
22. Chae EJ, Kim TB, Cho YS, Park CS, Seo JB, Kim N, et al. Airway measurement for airway remodeling defined by post-bronchodilator FEV1/FVC in asthma: investigation using inspiration-expiration computed tomography. Allergy Asthma Immunol Res. 2011 Apr;3(2):111–117. 10.4168/aair.2011.3.2.111
23. Bazan-Socha S, Mastalerz L, Cybulska A, Zareba L, Kremers R, Zabczyk M, et al. Prothrombotic state in asthma is related to increased levels of inflammatory cytokines, IL-6 and TNFalpha, in peripheral blood. Inflammation. 2017 Aug;40(4):1225–1235. 10.1007/s10753-017-0565-x
24. Branchett WJ, Stolting H, Oliver RA, Walker SA, Puttur F, Gregory LG, et al. A T cell-myeloid IL-10 axis regulates pathogenic IFN-gamma-dependent immunity in a mouse model of type 2-low asthma. J Allergy Clin Immunol. 2020 Feb;145(2):666–678, e669. 10.1016/j.jaci.2019.08.006
25. Wei, Han, Dai, Guo, Zhang, Zhao, et al., Exposure to ozone impacted Th1/Th2 imbalance of CD(4+) T cells and apoptosis of ASMCs underlying asthmatic progression by activating lncRNA PVT1-miR-15a-5p/miR-29c-3p signaling. Aging (Albany NY). 2020 Nov 20;12(24):25229–25255. 10.18632/aging.104124
26. Wang Y, Luo B, Zhang W, Zhu S, Chen C, Zhou L. The lncRNA PVT1/miR-590-5p/FSTL1 axis modulates the proliferation and migration of airway smooth muscle cells in asthma. Autoimmunity. 2021 May;54(3):138–147. 10.1080/08916934.2021.1897977
27. Lin QI, Qi QL, Hou S, Chen Z, Zhang L, Zhao HG, et al. LncRNA PVT1 acts as a tumor promoter in thyroid cancer and promotes tumor progression by mediating miR-423-5p-PAK3. Cancer Manag Res. 2020;12:13403–13413. 10.2147/CMAR.S283443
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.